NewAmsterdam Pharma Company N.V. (NAMS) Presents At Citi's Biopharma Back To School Conference Transcript

Core Insights - The Citi Back-to-school Biopharma Conference is being held for the 20th annual time, indicating its significance in the biopharma industry [1] - The conference features key executives from NewAmsterdam, including the CEO and CFO, highlighting the company's involvement and progress in the sector [1][2] Company Highlights - NewAmsterdam has made significant advancements in Phase III clinical trials, showcasing its commitment to research and development in biopharma [2]